NC
ALT icon

nVerses Capital’s Altimmune ALT Stock Holding History

nVerses Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.2K Buy
+24,408
New +$72.9K 0.11% 254

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

nVerses Capital's ALT Position: Q2 2026 in Review

nVerses Capital opened a new position in Altimmune (ALT) in Q2 2026: 24,408 shares worth $74.2K. The stake represents 0.11% of the portfolio and ranks #254 among its holdings.

140 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • nVerses Capital held 24,408 shares of Altimmune worth $74.2K as of Q2 2026.
  • Altimmune was a new nVerses Capital position in Q2 2026.
  • Altimmune made up 0.11% of nVerses Capital's portfolio in Q2 2026, its #254 holding.
  • 140 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.